Healthcare Business News

Abbott to buy Galapagos arthritis-drug rights for up to $1.35 billion

Posted: February 29, 2012 - 1:45 pm ET

Abbott Laboratories agreed to pay Galapagos as much as $1.35 billion for rights to an experimental rheumatoid arthritis drug that would compete with a Pfizer pill.


Advertisement | View Media Kit


What do you think?

Share your opinion. Send a letter to the Editor or Post a comment below.

Post a comment

Loading Comments Loading comments...



Switch to the new Modern Healthcare Daily News app

For the best experience of on your iPad, switch to the new Modern Healthcare app — it's optimized for your device but there is no need to download.